Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $6.67B | $6.69B | -0.28% |
Cost of Revenue | $1.54B | $1.55B | -0.77% |
Operating Income | $2.24B | $-4.32B | +151.76% |
Net Income | $1.31B | $-4.17B | +131.53% |
EPS (Basic) | $1.06 | $-3.34 | +131.74% |
EPS (Diluted) | $1.04 | $-3.34 | +131.14% |
SG&A Expense | $1.26B | $1.38B | -8.51% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $56.43B | $56.29B | +0.25% |
Current Assets | $16.9B | $14.04B | +20.37% |
Current Liabilities | $12.34B | $13.02B | -5.16% |
Stockholders' Equity | $19.16B | $17.54B | +9.25% |
Long-Term Debt | $24.95B | $25.19B | -0.96% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $1.76B | $2.22B | -20.82% |
Investing Cash Flow | $-415M | $-2.21B | +81.20% |
Financing Cash Flow | $-3.43B | $-1.36B | -151.73% |
Dividends Paid | $1.01B | $990M | +2.02% |
Share Buybacks | $730M | $400M | +82.50% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 33.6% | -64.6% | +98.20% |
Net Margin | 19.7% | — | — |
ROE | 6.9% | — | — |
ROA | 2.3% | — | — |
Current Ratio | $1.369 | — | — |
Other companies in Biotechnology